Bivalent jabs are no better than the original concoction

And those ones aren't exactly game-changers.

Although studies in mice suggested that the new bivalent shot, which was engineered to target both the latest Omicron variants and earlier incarnations of SARS-CoV-2, worked well, it turns out that humans don't have the same immune responses as mice.

This recently-published study of humans, conducted by scientists from Columbia University and the University of Michigan, concluded:

“Boosting with a new bivalent mRNA vaccine targeting both BA.4/BA.5 and an ancestral SARS76 CoV-2 strain did not elicit a discernibly superior virus-neutralizing antibody responses compared [to] boosting with an original monovalent vaccine.”

So, injecting a concoction targeting the Alpha variant spike (a strain that's long gone) is just as effective against Omicron as an injection geared specifically towards Omicron.

And how effective is that? Well, the multi-jabbed are still testing positive and getting sick 'with Covid' and, according to the last available data for England (end of March 2022):

That's negative efficacy. These jabs are making people MORE vulnerable to COVID-19.